| Literature DB >> 33854087 |
Mohd Rizal Abdul Manaf1, Azmawati Mohammed Nawi2, Noorlaili Mohd Tauhid3, Hanita Othman4, Mohd Rizam Abdul Rahman2, Hanizah Mohd Yusoff2, Nazaruddin Safian2, Pei Yuen Ng5, Zahara Abdul Manaf6, Nor Ba'yah Abdul Kadir7, Kevina Yanasegaran5, Siti Munirah Abdul Basir6, Sowmya Ramakrishnappa2, Kurubaran Ganasegeran8.
Abstract
Public health systems are concerned with the commensurate rise of metabolic syndrome (MetS) incidence across populations worldwide, due to its tendency to amplify greater risk of diabetes and cardiovascular diseases within communities. This study aimed to determine the prevalence of MetS and its associated risk factors among staffs in a Malaysian public university. A cross-sectional study was conducted among 538 staffs from the Universiti Kebangsaan Malaysia (UKM) between April and June 2019. MetS was defined according to JIS "Harmonized" criteria. A questionnaire that consisted of items on socio-demographics, lifestyle risk behaviors and personal medical history information was administered to participants. Subsequently, a series of physical examination and biochemical assessment was conducted at the hall or foyer of selected faculties in the university. Descriptive and inferential statistics were conducted using SPSS version 22.0. Multivariate models were yielded to determine the risk factors associated with MetS. Statistical significance was set at P < 0.05. The overall prevalence of MetS was 20.6%, with men having greater prevalence than women (24.9% vs. 18.3%). Prevalence of MetS increased with age. Factors contributed to MetS in the overall sample were BMI, hypertension, diabetes and physical activity of moderate intensity. Diabetes and hypertension were significantly associated with MetS in men, whereas BMI, diabetes and hyperlipidemia were significantly associated with MetS in women. Lifestyle behaviors and cardio-metabolic risk factors were associated with MetS for the overall sample, and across genders.Entities:
Year: 2021 PMID: 33854087 PMCID: PMC8047014 DOI: 10.1038/s41598-021-87248-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Sample characteristics (n = 538).
| Characteristics | n (%) |
|---|---|
| Men | 189 (35.1) |
| Women | 349 (64.9) |
| < 35 | 28 (5.2) |
| 35–44 | 309 (57.4) |
| 45–54 | 128 (23.8) |
| ≥ 55 | 73 (13.6) |
| No | 378 (92.6) |
| Yes | 30 (7.4) |
| No | 403 (98.5) |
| Yes | 6 (1.5) |
| < 30 | 140 (74.1) |
| ≥ 30 | 49 (25.9) |
| Low intensity | 155 (29.6) |
| Moderate intensity | 143 (27.3) |
| High intensity | 226 (43.1) |
| No | 444 (84.3) |
| Yes | 83 (15.7) |
| No | 502 (95.1) |
| Yes | 26 (4.9) |
| No | 455 (86.0) |
| Yes | 74 (14.0) |
| No | 427 (79.4) |
| Yes | 111 (20.6) |
*MetS denotes metabolic syndrome.
Prevalence of MetS and its components by age groups.
| Characteristics | Age group (years) | ||||
|---|---|---|---|---|---|
| < 35 | 35–44 | 45–54 | ≥ 55 | ||
| MetS | 3 (10.7) | 51 (16.5) | 34 (26.6) | 23 (31.5) | 0.005 |
| MetS | 1 (14.3) | 20 (20.4) | 16 (34.0) | 10 (27.0) | 0.299 |
| Raised WC | 4 (57.1) | 55 (56.1) | 30 (63.8) | 24 (64.9) | 0.733 |
| Raised TG | 2 (28.6) | 30 (30.6) | 18 (38.3) | 7 (18.9) | 0.294 |
| Low HDL-c | 1 (14.3) | 11 (11.2) | 10 (21.3) | 4 (10.8) | 0.385 |
| Raised glucose | 0 (0.0) | 11 (11.2) | 11 (23.4) | 12 (32.4) | 0.013 |
| Raised SBP | 2 (28.6) | 27 (27.6) | 20 (42.6) | 24 (64.9) | 0.001 |
| Raised DBP | 2 (28.6) | 36 (36.7) | 26 (55.3) | 20 (54.1) | 0.082 |
| MetS | 2 (9.5) | 31 (14.7) | 18 (22.2) | 13 (36.1) | 0.010 |
| Raised WC | 9 (42.9) | 121 (57.3) | 54 (66.7) | 28 (77.8) | 0.024 |
| Raised TG | 0 (0.0) | 19 (9.0) | 12 (14.8) | 10 (27.8) | 0.003 |
| Low HDL-c | 8 (38.1) | 58 (27.5) | 17 (21.0) | 9 (25.0) | 0.413 |
| Raised glucose | 1 (4.8) | 16 (7.6) | 16 (19.8) | 9 (25.0) | 0.002 |
| Raised SBP | 4 (19.0) | 36 (17.1) | 35 (43.2) | 24 (66.7) | < 0.001 |
| Raised DBP | 4 (19.0) | 58 (27.5) | 35 (43.2) | 13 (36.1) | 0.035 |
Risk factors associated with MetS by Pearson chi-square and binary logistic regressions.
| Risk factors | MetS in overall samples (n = 538) | cOR (95% CI) | MetS in Men (n = 189) | cOR | MetS in Women (n = 349) | cOR (95% CI) | |||
|---|---|---|---|---|---|---|---|---|---|
| Yes n (%) | No n (%) | Yes | No | Yes | No | ||||
| Men | 47 (24.9) | 142 (75.1) | 1.5 (0.9–2.2) | – | – | – | – | – | – |
| Women | 64 (18.3) | 285 (81.7) | 1 | – | – | – | – | – | – |
| No | 75 (19.8) | 303 (80.2) | 1 | 28 (23.5) | 91 (76.5) | 1 | 47 (18.1) | 212 (81.9) | # |
| Yes | 7 (23.3) | 23 (76.7) | 1.2 (0.5–3.3) | 7 (24.1) | 22 (75.9) | 1.1 (0.4–2.5) | 0 (0.0) | 1 (100.0) | # |
| No | 79 (19.6) | 324 (80.4) | 1 | 34 (23.3) | 112 (76.7) | 1 | 45 (17.5) | 212 (82.5) | 1 |
| Yes | 4 (66.7) | 2 (33.3) | 8.2 (1.4–45.0)** | 2 (66.7) | 1 (33.3) | 6.5 (0.6–76.0) | 2 (66.7) | 1 (33.3) | 9.4 (1.2–100.0)* |
| < 30 | 58 (14.6) | 338 (85.4) | 1 | 29 (20.7) | 111 (79.3) | 1 | 29 (11.3) | 227 (88.7) | 1 |
| ≥ 30 | 53 (37.3) | 89 (62.7) | 3.5 (2.2–5.4)*** | 18 (36.7) | 31 (63.3) | 2.2 (1.1–4.5)** | 35 (37.6) | 58 (62.4) | 4.7 (2.7–8.3)*** |
| Low | 24 (15.5) | 131 (84.5) | 1 | 9 (20.5) | 35 (79.5) | 1 | 15 (13.5) | 96 (86.5) | 1 |
| Moderate | 36 (25.2) | 107 (74.8) | 1.8 (1.1–3.3)** | 15 (33.3) | 30 (66.7) | 1.9 (0.7–5.1) | 21 (21.4) | 77 (78.6) | 1.7 (0.8–3.6) |
| High | 48 (21.2) | 178 (78.8) | 1.5 (0.9–2.5) | 23 (23.5) | 75 (76.5) | 1.2 (0.5–2.8) | 25 (19.5) | 103 (80.5) | 1.5 (0.8–3.1) |
| No | 73 (16.4) | 371 (83.6) | 1 | 28 (19.4) | 116 (80.6) | 1 | 45 (15.0) | 255 (85.0) | 1 |
| Yes | 36 (43.4) | 47 (56.6) | 3.9 (2.3–6.4)*** | 18 (45.0) | 22 (55.0) | 3.4 (1.6–7.1)** | 18 (41.9) | 25 (58.1) | 4.1 (2.1–8.1)*** |
| No | 94 (18.7) | 408 (81.3) | 1 | 37 (21.9) | 132 (78.1) | 1 | 57 (17.1) | 276 (82.9) | 1 |
| Yes | 14 (53.8) | 12 (46.2) | 5.1 (2.3–11.3)*** | 9 (56.3) | 7 (43.8) | 4.6 (1.6–13.1)** | 5 (50.0) | 5 (50.0) | 4.8 (1.3–16.7)** |
| No | 87 (19.1) | 368 (80.9) | 1 | 35 (25.2) | 104 (74.8) | 1 | 52 (16.5) | 264 (83.5) | 1 |
| Yes | 22 (29.7) | 52 (70.3) | 1.8 (1.1–3.1)** | 11 (23.9) | 35 (76.1) | 0.9 (0.4–1.2) | 11 (39.3) | 17 (60.7) | 3.3 (1.5–7.4)** |
*Statistical significance (P < 0.05). **Statistical significance (P < 0.005). ***Statistical significance (P < 0.001). cOR (crude odds ratio). #cOR could not be yielded as one cell contained zero count during crosstabs.
Risk factors associated with MetS in overall samples (adjusted for age) by multiple logistic regression (Backward Wald).
| Risk factors | SE | Wald | Exp ( | 95% CI | VIF | ||
|---|---|---|---|---|---|---|---|
| No | Ref | Ref | Ref | Ref | Ref | Ref | 1.037 |
| Yes | − 1.7 | 0.9 | 2.8 | 5.3 | 0.7–33.0 | 0.095 | |
| < 30 | Ref | Ref | Ref | Ref | Ref | Ref | 1.056 |
| ≥ 30 | − 1.1 | 0.3 | 15.6 | 3.1 | 1.8–5.5 | < 0.001 | |
| Low | Ref | Ref | Ref | Ref | Ref | Ref | 1.004 |
| Moderate | − 0.9 | 0.4 | 6.3 | 2.5 | 1.2–5.0 | 0.015 | |
| High | − 0.5 | 0.3 | 2.3 | 1.7 | 0.8–3.3 | 0.126 | |
| No | Ref | Ref | Ref | Ref | Ref | Ref | 1.133 |
| Yes | − 0.7 | 0.3 | 4.1 | 2.0 | 1.1–4.3 | 0.023 | |
| No | Ref | Ref | Ref | Ref | Ref | Ref | 1.048 |
| Yes | − 1.3 | 0.5 | 6.5 | 3.9 | 1.3–11.4 | 0.011 | |
Exp(B) gives adjusted odds ratio (aOR). VIF (Variance Inflation Factor). Ref (Reference category).
Risk factors associated with MetS in men (adjusted for age) by multiple logistic regression (Backward Wald).
| Risk factors | SE | Wald | Exp ( | 95% CI | VIF | ||
|---|---|---|---|---|---|---|---|
| < 30 | Ref | Ref | Ref | Ref | Ref | Ref | 1.062 |
| ≥ 30 | − 0.7 | 0.4 | 3.6 | 2.1 | 0.9–4.5 | 0.058 | |
| No | Ref | Ref | Ref | Ref | Ref | Ref | 1.112 |
| Yes | − 0.9 | 0.4 | 4.8 | 2.4 | 1.1–5.4 | 0.029 | |
| No | Ref | Ref | Ref | Ref | Ref | Ref | 1.050 |
| Yes | − 1.3 | 0.6 | 5.6 | 3.8 | 1.3–11.1 | 0.031 | |
Exp(B) gives the adjusted odds ratio (aOR). VIF (Variance Inflation Factor). Ref (Reference category).
Risk factors associated with MetS in women (adjusted for age) by multiple logistic regression (Backward Wald).
| Risk factors | SE | Wald | Exp ( | 95% CI | VIF | ||
|---|---|---|---|---|---|---|---|
| < 30 | Ref | Ref | Ref | Ref | Ref | Ref | 1.081 |
| ≥ 30 | − 1.5 | 0.4 | 18.5 | 4.6 | 2.3–8.2 | < 0.001 | |
| No | Ref | Ref | Ref | Ref | Ref | Ref | 1.042 |
| Yes | − 2.2 | 0.9 | 5.2 | 4.2 | 1.4–9.2 | 0.023 | |
| No | Ref | Ref | Ref | Ref | Ref | Ref | 1.114 |
| Yes | − 1.2 | 0.6 | 4.7 | 3.2 | 1.1–6.0 | 0.030 | |
Exp(B) gives the adjusted odds ratio (aOR). VIF (Variance Inflation Factor). Ref (Reference category).